Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the CENDA registry

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F21%3A10422119" target="_blank" >RIV/00064203:_____/21:10422119 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11320/21:10422119 RIV/00669806:_____/21:10422119 RIV/00216208:11120/21:43921101 RIV/00216208:11140/21:10422119 a 3 dalších

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=RrqXz5He15" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=RrqXz5He15</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/pedi.13184" target="_blank" >10.1111/pedi.13184</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the CENDA registry

Popis výsledku v původním jazyce

INTRODUCTION: Increased access to modern technologies is not always accompanied by a decrease in HbA1c. The aim of this study was to identify changes in the proportion of CGM users since 2017, when general reimbursement for CGM became effective in Czechia, and to test whether HbA1c is associated with the percentage of time spent on CGM. METHODS: All T1D children in the Czech national ČENDA registry (3197 children) were categorized according to their time spent on CGM and associations with age, sex, center size and HbA1c were tested with calendar year as a stratification factor. RESULTS: The proportion of children with any CGM use increased from 37.9% in 2017 to 50.3% in 2018 and 74.8% in 2019. Of the CGM users, 16%, 28%, and 41% of the children spent &gt; 70% of their time on CGM over the 3 years of the study period, with an overrepresentation of children in the &lt; 10 years age group vs. the older age groups (p &lt; 0.001). The proportion of CGM users differed among centers and was positively associated with a large center size (&gt; 100 patients) (p &lt; 0.001). HbA1c was negatively associated with the time spent on CGM (p &lt; 0.001). CONCLUSIONS: A rapid increase in CGM use was reported over the three years after general reimbursement. HbA1c was associated with time spent on CGM, a continuing decrease was observed in the &gt;70% category. Reimbursement for CGM likely contributes to the improvement of T1D control at the population level.

Název v anglickém jazyce

Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the CENDA registry

Popis výsledku anglicky

INTRODUCTION: Increased access to modern technologies is not always accompanied by a decrease in HbA1c. The aim of this study was to identify changes in the proportion of CGM users since 2017, when general reimbursement for CGM became effective in Czechia, and to test whether HbA1c is associated with the percentage of time spent on CGM. METHODS: All T1D children in the Czech national ČENDA registry (3197 children) were categorized according to their time spent on CGM and associations with age, sex, center size and HbA1c were tested with calendar year as a stratification factor. RESULTS: The proportion of children with any CGM use increased from 37.9% in 2017 to 50.3% in 2018 and 74.8% in 2019. Of the CGM users, 16%, 28%, and 41% of the children spent &gt; 70% of their time on CGM over the 3 years of the study period, with an overrepresentation of children in the &lt; 10 years age group vs. the older age groups (p &lt; 0.001). The proportion of CGM users differed among centers and was positively associated with a large center size (&gt; 100 patients) (p &lt; 0.001). HbA1c was negatively associated with the time spent on CGM (p &lt; 0.001). CONCLUSIONS: A rapid increase in CGM use was reported over the three years after general reimbursement. HbA1c was associated with time spent on CGM, a continuing decrease was observed in the &gt;70% category. Reimbursement for CGM likely contributes to the improvement of T1D control at the population level.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30202 - Endocrinology and metabolism (including diabetes, hormones)

Projekt

<a href="/cs/project/TJ02000342" target="_blank" >TJ02000342: Vývoj a klinická aplikace softwaru hybridní umělé slinivky AndroidAPS</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Pediatric Diabetes

ISSN

1399-543X

e-ISSN

—

Svazek periodika

22

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

9

Strana od-do

439-447

Kód UT WoS článku

000618881000001

EID výsledku v databázi Scopus

2-s2.0-85104048015